01-04-2012 | Original Article
The antinociceptive effect of intrathecal tramadol in rats: the role of alpha 2-adrenoceptors in the spinal cord
Published in: Journal of Anesthesia | Issue 2/2012
Login to get accessAbstract
Purposes
The alpha 2 (α2)-adrenoceptor is highly important in the antinociception of tramadol administered systemically and intrathecally. However, it is unclear whether tramadol at the spinal level exerts an antinociceptive effect by directly binding with α2-adrenoceptors in the spinal cord. This study was conducted to investigate the relationship between α2-adrenoceptors and the antinociception of tramadol at the spinal level.
Methods
The rat formalin test was designed to determine whether the intrathecal α2-adrenoceptor antagonist yohimbine could reverse the antinociceptive effect of intrathecal tramadol. The binding affinity of tramadol for α2-adrenoceptors in the spinal cord was determined by radioligand binding assay using the labeled α2-adrenoceptor antagonist [3H]-yohimbine.
Results
The nociceptive test showed that intrathecal tramadol induced significant antinociception whereas pretreatment with intrathecal yohimbine partially reversed this antinociception. Scatchard analysis of the binding data showed [3H]-yohimbine had high affinity (K
d = 1.79 nM) for the α2-adrenoceptor in the rat spinal cord, and that tramadol inhibited specific binding of [3H]-yohimbine with the spinal cord membranes with a high affinity constant (K
i = 34.14 μM) and an IC50 of 68.25 μM, which indicated that tramadol was much less potent than [3H]-yohimbine at binding with α2-adrenoceptors of the spinal cord.
Conclusion
The results suggested that, with very weak binding affinity for α2-adrenoceptors, the antinociception of intrathecal tramadol is partially related to α2-adrenoceptors, and its intrathecal antinociception may mainly involve its indirect activation of α2-adrenoceptors in the spinal cord.